tiprankstipranks
Trending News
More News >
ForFarmers N.V. (NL:FFARM)
:FFARM
Advertisement

ForFarmers N.V. (FFARM) AI Stock Analysis

Compare
1 Followers

Top Page

NL:FFARM

ForFarmers N.V.

(LSE:FFARM)

Rating:64Neutral
Price Target:
€5.00
▲(12.11% Upside)
ForFarmers N.V. demonstrates strong valuation metrics with a low P/E ratio and high dividend yield, making it an attractive investment. However, technical indicators suggest caution due to overbought conditions. Financial performance shows improvement, but revenue decline and cash flow issues pose risks. The absence of earnings call data limits insight into future guidance.

ForFarmers N.V. (FFARM) vs. iShares MSCI Netherlands ETF (EWN)

ForFarmers N.V. Business Overview & Revenue Model

Company DescriptionForFarmers N.V. is a leading European agricultural company specializing in the production and supply of animal feed and related products. Based in the Netherlands, the company operates primarily in the livestock sector, providing nutritional solutions and services tailored for farmers raising pigs, poultry, and cattle. ForFarmers N.V. also engages in the production of raw materials and additives, along with offering expert advice to improve farm management and efficiency in animal husbandry.
How the Company Makes MoneyForFarmers N.V. generates revenue primarily through the sale of animal feed products, which constitute the bulk of its income. The company's revenue model is based on direct sales to farmers, enabling it to establish strong relationships within the agricultural community. Key revenue streams include the sale of compound feeds, specialty feeds, and other nutritional products, as well as value-added services such as feed formulations and farm management consulting. Additionally, ForFarmers may engage in strategic partnerships with local and international agricultural businesses to enhance its product offerings and expand its market reach. Factors contributing to its earnings include the demand for high-quality feed in livestock production, efficient supply chain management, and the company's ability to innovate and adapt to changing agricultural practices.

ForFarmers N.V. Financial Statement Overview

Summary
ForFarmers N.V. shows operational improvement with rising profit margins and strong cash flow generation. However, revenue decline and reduced free cash flow indicate potential challenges. The balance sheet remains stable with moderate leverage, but declining equity levels should be monitored.
Income Statement
65
Positive
ForFarmers N.V. experienced revenue fluctuations, with a recent decline from 2023 to 2024. However, the gross profit margin improved to 17.52% in 2024 from 16.04% in 2023, indicating better cost management. The net profit margin turned positive at 1.14% in 2024, recovering from a loss in 2023. The EBIT and EBITDA margins also improved, reflecting enhanced operational efficiency. Despite these improvements, the revenue decline and past volatility in earnings pose challenges.
Balance Sheet
70
Positive
The company's debt-to-equity ratio stands at 0.49, indicating moderate leverage. Return on equity improved to 9.56% in 2024, demonstrating better profitability relative to equity. The equity ratio is 34.85%, showing a stable financial position but a slight decrease from previous years. Overall, the balance sheet reflects a stable capital structure with manageable debt levels, though equity has slightly decreased over the years.
Cash Flow
60
Neutral
Free cash flow declined by 21.23% from 2023 to 2024, pointing to potential cash management issues. The operating cash flow to net income ratio is 2.24, indicating strong cash generation relative to net income. However, the decrease in free cash flow suggests challenges in sustaining cash reserves. While operating cash flow remains robust, the decreasing free cash flow warrants attention.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.75B2.97B3.31B2.67B2.35B
Gross Profit481.00M477.30M494.80M436.27M433.18M
EBITDA82.50M52.70M69.30M66.11M70.81M
Net Income31.40M-1.00M18.00M12.00M14.15M
Balance Sheet
Total Assets942.10M840.80M1.02B943.44M816.69M
Cash, Cash Equivalents and Short-Term Investments50.70M46.50M68.40M68.27M68.66M
Total Debt159.80M108.50M166.80M131.64M80.88M
Total Liabilities603.80M520.40M676.20M577.18M454.20M
Stockholders Equity328.40M311.50M335.10M360.53M356.93M
Cash Flow
Free Cash Flow43.40M55.10M12.90M15.05M62.39M
Operating Cash Flow70.20M86.50M48.20M54.68M98.14M
Investing Cash Flow-78.30M-7.20M-34.80M-55.64M-28.81M
Financing Cash Flow-7.40M-66.90M-17.80M-2.49M-47.53M

ForFarmers N.V. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price4.46
Price Trends
50DMA
4.16
Positive
100DMA
4.14
Positive
200DMA
3.86
Positive
Market Momentum
MACD
0.11
Positive
RSI
51.99
Neutral
STOCH
20.34
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:FFARM, the sentiment is Neutral. The current price of 4.46 is below the 20-day moving average (MA) of 4.56, above the 50-day MA of 4.16, and above the 200-day MA of 3.86, indicating a neutral trend. The MACD of 0.11 indicates Positive momentum. The RSI at 51.99 is Neutral, neither overbought nor oversold. The STOCH value of 20.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NL:FFARM.

ForFarmers N.V. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
€398.08M7.7116.22%4.48%8.76%195.20%
63
Neutral
$20.52B14.80-2.68%3.09%1.95%-4.76%
€1.01B14.868.84%
€485.03M17.785.83%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NL:FFARM
ForFarmers N.V.
4.48
1.53
51.85%
GB:0QHL
Corbion NV
17.45
-5.38
-23.57%
GB:0MKM
Sligro Food Group NV
10.94
-1.43
-11.56%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 15, 2025